Wiley Chambers, MD: The Work of an FDA Legend
When it comes to the medications we use and prescribe every day in our clinics, our community has been led by a steadfast figure for more than 36 years: ophthalmologist Wiley A. Chambers, MD.
Related Articles
Surgical Success Is Maintained One Year After Hemiface and Whole Eye Transplant
No signs of tissue rejection, phthisis, or sympathetic ophthalmia have been seen in the recipient of the first complete eye and partial face transplant, though…
Innovations in Medical Glaucoma: Preservative-Free Latanoprost – Eyetube
Jason Bacharach, MD, joins host I. Paul Singh, MD, to discuss a study exploring patient-reported outcomes after switching to or starting a preservative-free latanoprost formulation.…
Functional Outcomes and Quality of Life in Geographic Atrophy in the Clinical Setting
Geographic atrophy (GA), an advanced, progressive form of dry age-related macular degeneration, affects approximately 5 million people worldwide, and results in significant visual function decline.1,2…
A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision research
With an evolving understanding and new discoveries in extracellular vesicle (EV) biology and their implications in health and disease, the significant diagnostic and therapeutic potential…
IRIS Registry Data Analysis: RPB/Academy Award
Research to Prevent Blindness has opened applications for four IRIS Registry research grants. The deadline to apply is Jan. 31.
Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma
To compare the outcomes of intravitreal melphalan (IVit-M) versus intravitreal topotecan (IVit-T) for vitreous seeds (VS) in retinoblastoma (RB).
Microscope-Integrated OCT-Assisted Real-time Monitoring of Central Corneal Thickness During Corneal Cross-linking | Journal of Refractive Surgery
Purpose To assess real-time intraoperative pachymetry changes occurring during corneal cross-linking (CXL) using microscope-integrated optical coherence tomography (Mi-OCT) and compare accuracy of various modalities of…
Reviews Supplements RP-Year in Review
Wills Eye Resident Series : A patient presents with decreased vision after an injury , p. 62 medicare Q & A 2024 Reimbursement Update Wills…
Type 3 Macular Neovascularization in Age-related Macular Degeneration
To identify baseline OCT predictors of the 3-year macular atrophy (MA) development for type 3 (T3) macular neovascularization (MNV) secondary to neovascular age-related macular degeneration…
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening
This randomized clinical trial examines the effectiveness of microdrops with phenylephrine and tropicamide for screening for retinopathy of prematurity in preterm infants compared with commercial…
